Latest Articles

The Italian Parliament has established an intergroup on the legalisation of cannabis following calls to address the need for its decriminalisation and shortages of medical cannabis. More than 50 members of Parliament already have applied to join the intergroup, mainly from the left. For now, no one from the centre-right has asked to participate. The impetus behind this movement is multifaceted but at the forefront is Walter de Benedetto, a patient with rheumatoid arthritis potentially…
Those attempting to track the meandering Brexit trail in the three years since the referendum which decided that the United Kingdom (UK) would leave the European Union (EU) are well aware that the general election on 12 December most likely will determine the path forward. What that might mean for the cannabis market in the UK is less discussed. Election front-runners, the Conservatives and Labour Parties, which recent polls projected to have 41 and 29…
On 24 September, European regulators cleared the way for GW Pharma’s cannabinoid medicinal product to treat patients with two rare, severe forms of epilepsy. The European Commission approved Epidyolex to treat seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome in patients aged two and over. The drug is the first to be approved using the centralized procedure, meaning that it is authorized to be placed on the market throughout the 28 Member States…